» Articles » PMID: 20081375

Yin Yang 1 Expression in Human Tumors

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2010 Jan 19
PMID 20081375
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The Yin Yang 1 (YY1) transcription factor has been identified to target a plethora of potential target genes, the products of which are important for proliferation and differentiation. The mechanisms of YY1 action are related to its ability to initiate, activate or repress transcription depending on the context in which it binds. This article sheds a light on the role that YY1 plays in different human types of cancer, through the context of its expression levels. Moreover, we concentrate on the most relevant studies that have focused on YY1 regulation. we performed computational analysis on thirty-six publicly available Gene expression Omnibus (GeO) datasets, to further understand whether differences in YY1 transcript levels occur in different cancer types when compared with relative normal tissue, benign tumor or its metastatic counterpart. Our results suggest a dual role of YY1 in cancer development, either through overexpression or under-expression, depending on the tumor type.

Citing Articles

Therapeutic Implications of Targeting YY1 in Glioblastoma.

Navasardyan I, Zaravinos A, Bonavida B Cancers (Basel). 2024; 16(11).

PMID: 38893192 PMC: 11171050. DOI: 10.3390/cancers16112074.


Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma.

Xue T, Lin J, He Y, Li J, Liu Z, Jia Y Heliyon. 2024; 10(2):e24376.

PMID: 38312674 PMC: 10835246. DOI: 10.1016/j.heliyon.2024.e24376.


Cross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis.

Baritaki S, Zaravinos A Cancers (Basel). 2023; 15(20).

PMID: 37894300 PMC: 10605344. DOI: 10.3390/cancers15204932.


Yin Yang 1 suppresses tumor invasion and metastasis in nasopharyngeal carcinoma by negatively regulating eIF4E transcriptional activity and expression.

Li M, Duan Y, Wei J, Chen S, Xue C, Zheng L Am J Cancer Res. 2023; 13(8):3763-3780.

PMID: 37693135 PMC: 10492101.


Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.

Hosea R, Hillary S, Wu S, Kasim V Cancers (Basel). 2023; 15(13).

PMID: 37444616 PMC: 10340792. DOI: 10.3390/cancers15133506.